Beta
Company data is growing.
← All companies
/
Top lists
/
Zimmer Biomet Holdings
Zimmer Biomet Holdings
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
7 684
7 824
7 933
7 982
7 025
7 836
6 940
7 394
7 679
8 232
Operating profit (EBIT)
826
808
34
1 138
−88
780
696
1 278
1 286
1 098
Net income attributable to shareholders
306
1 814
−379
1 132
−139
402
231
1 024
904
705
EBIT margin
10,8%
10,3%
0,4%
14,3%
−1,3%
10,0%
10,0%
17,3%
16,7%
13,3%
Gross margin
69,0%
72,7%
71,4%
71,8%
69,7%
70,1%
70,9%
71,8%
71,5%
69,7%
Operating cash flow
1 632
1 582
1 747
1 586
1 205
1 499
1 356
1 582
1 499
1 697
Free cash flow
1 448
1 426
1 585
1 379
1 087
1 327
1 168
1 291
1 296
1 473
Cash
634
524
543
618
802
479
376
416
526
592
Interest-bearing debt
—
—
—
—
—
1
—
—
—
—
−2 000
0
2 000
4 000
6 000
8 000
10 000
−5,0%
0,0%
5,0%
10,0%
15,0%
20,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
7 684
7 824
7 933
7 982
7 025
7 836
6 940
7 394
7 679
8 232
826
808
34
1 138
−88
780
696
1 278
1 286
1 098